Genteal Ointment
Pricing Report NDC 0065-0518-01

Current NADAC: $2.48474 per GM · Effective Aug 19, 2026 · Est. package price $8.70 (3.5 GM)

Current Package Pricing Information

The current wholesale acquisition cost for Genteal Tears Night-time (NDC 0065-0518-01) is $2.48474 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human over the counter drug provided by Alcon Laboratories, Inc., this medication is distributed in a 1 TUBE in 1 CARTON / 3.5 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$2.48474
Per GM

Effective Date
Aug 19, 2026
Billable Units
3.5 GM
Estimated Package Price
$8.70
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE in 1 CARTON / 3.5 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2020, the NADAC wholesale price for (NDC ) has moved within a range of $2.16981 to $2.69069 per GM. Over this 6 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$2.1698 - $2.6907
Market Volatility
24.01% Variance
Latest Trend
0.21%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $2.48474 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jul 22, 2026 $2.48995 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jun 17, 2026 $2.49188 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 20, 2026 $2.48852 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Apr 22, 2026 $2.49626 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Mar 18, 2026 $2.48956 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Feb 18, 2026 $2.36762 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jan 21, 2026 $2.37632 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Dec 17, 2025 $2.37524 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Nov 19, 2025 $2.48501 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Oct 22, 2025 $2.49493 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Aug 20, 2025 $2.49870 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026